Salud financiera de hoja de balance de Onyx Healthcare

Salud financiera controles de criterios 5/6

Onyx Healthcare tiene un patrimonio de accionistas total de NT$1.5B y una deuda total de NT$216.6M, lo que sitúa su ratio deuda-patrimonio en 14.6%. Sus activos y pasivos totales son NT$2.1B y NT$609.0M respectivamente. El BAIT de Onyx Healthcare es de NT$121.2M, por lo que su ratio de cobertura de intereses es de -36.9. Tiene efectivo e inversiones a corto plazo que ascienden a NT$284.5M.

Información clave

14.6%

Ratio deuda-patrimonio

NT$216.62m

Deuda

Ratio de cobertura de intereses	-36.9x
Efectivo	NT$284.54m
Patrimonio	NT$1.49b
Total pasivo	NT$608.96m
Activos totales	NT$2.09b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Onyx Healthcare Inc.'s (GTSM:6569) Stock Been Rising: Are Strong Financials Guiding The Market?

Feb 05

Should You Or Shouldn't You: A Dividend Analysis on Onyx Healthcare Inc. (GTSM:6569)

Jan 14

Will Onyx Healthcare (GTSM:6569) Multiply In Value Going Forward?

Dec 23

Did You Miss Onyx Healthcare's (GTSM:6569) 14% Share Price Gain?

Dec 02

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$823.0M) de 6569 superan a sus pasivos a corto plazo (NT$394.6M).

Pasivo a largo plazo: Los activos a corto plazo de 6569 (NT$823.0M) superan a sus pasivos a largo plazo (NT$214.4M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 6569 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 6569 ha crecido de 0% a 14.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de 6569 está bien cubierta por el flujo de caja operativo (52.8%).

Cobertura de intereses: 6569 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.

Salud financiera de hoja de balance de Onyx Healthcare

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Third quarter 2024 earnings released: EPS: NT$0.69 (vs NT$1.70 in 3Q 2023)

Onyx Healthcare Inc. to Report Q3, 2024 Results on Nov 06, 2024

Second quarter 2024 earnings released: EPS: NT$1.15 (vs NT$1.77 in 2Q 2023)

Investor sentiment deteriorates as stock falls 17%

Onyx Healthcare Inc. to Report Q2, 2024 Results on Aug 05, 2024

Upcoming dividend of NT$5.00 per share

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: NT$1.52 (vs NT$1.69 in 1Q 2023)

Onyx Healthcare Inc. to Report Q1, 2024 Results on May 08, 2024

Onyx Healthcare Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: NT$7.65 (vs NT$6.24 in FY 2022)

Investor sentiment improves as stock rises 16%

Onyx Healthcare Inc., Annual General Meeting, May 27, 2024

Now 22% undervalued after recent price drop

Onyx Healthcare Inc. Announces Executive Changes

Onyx Healthcare Inc. Announces Executive Changes

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 18%

Second quarter 2023 earnings released: EPS: NT$2.03 (vs NT$0.96 in 2Q 2022)

Investor sentiment deteriorates as stock falls 17%

New major risk - Share price stability

Investor sentiment improves as stock rises 26%

Upcoming dividend of NT$5.00 per share at 3.6% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: NT$6.24 (vs NT$4.22 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.61 (vs NT$0.55 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$0.96 (vs NT$0.63 in 2Q 2021)

Upcoming dividend of NT$4.00 per share

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Onyx Healthcare Inc., Annual General Meeting, May 31, 2022

Third quarter 2021 earnings released: EPS NT$0.55 (vs NT$1.24 in 3Q 2020)

Upcoming dividend of NT$5.50 per share

Second quarter 2021 earnings released: EPS NT$0.70 (vs NT$2.10 in 2Q 2020)

Director Yung-Shun Chuang has joined 7th company board

First quarter 2021 earnings released: EPS NT$0.63 (vs NT$0.10 in 1Q 2020)

Here's How We Evaluate Onyx Healthcare Inc.'s (GTSM:6569) Dividend

Returns On Capital At Onyx Healthcare (GTSM:6569) Paint A Concerning Picture

Full year 2020 earnings released: EPS NT$6.07 (vs NT$8.70 in FY 2019)

Shareholders Of Onyx Healthcare (GTSM:6569) Must Be Happy With Their 46% Return

Onyx Healthcare Inc., Annual General Meeting, May 25, 2021

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS NT$6.07 (vs NT$8.70 in FY 2019)

New 90-day high: NT$142

Onyx Healthcare Inc.'s (GTSM:6569) Stock Been Rising: Are Strong Financials Guiding The Market?

Should You Or Shouldn't You: A Dividend Analysis on Onyx Healthcare Inc. (GTSM:6569)

Will Onyx Healthcare (GTSM:6569) Multiply In Value Going Forward?

Did You Miss Onyx Healthcare's (GTSM:6569) 14% Share Price Gain?

Third quarter 2020 earnings released: EPS NT$1.37

New 90-day low: NT$120

New 90-day low: NT$120

New 90-day low: NT$133

First half earnings released

New 90-day high - NT$182

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera